Patent Yard Sign in
Expired Canadian patentCanada

Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

CA 2174097 C · Owner: Rhone-Poulenc Rorer Pharmaceuticals Inc. · Inventors: Molino, Bruce F.; Klein, Scott I.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to azacycloalkylalkanoyl peptides and pseudopeptides which inhibit platelet aggregation and thrombus formation thereby being useful in the prevention and treatment of thrombosis associated with disease states such as myocardial infarction stroke, peripheral arterial disease, and disseminated intravascular coagulation to methods for the prevention or treatment of thrombosis in a mammal in need of such therapy comprising the administration of a therapeutically effective amount of such compounds and to, pharmaceutical compositions comprising such compounds.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 17, 1994 and granted June 4, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 17, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 17, 1994
GrantedJune 4, 2002
Term endedOctober 17, 2014
Patent numberCA 2174097 C
Classification (IPC)C07K5/02 +2 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedOct 17, 1994Patent grantedJune 4, 2002Term endedOct 17, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.